{"id":292,"date":"2025-01-04T10:55:24","date_gmt":"2025-01-04T10:55:24","guid":{"rendered":"https:\/\/whmnews.ir\/En\/?p=292"},"modified":"2025-01-04T10:55:24","modified_gmt":"2025-01-04T10:55:24","slug":"tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer","status":"publish","type":"post","link":"http:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/","title":{"rendered":"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer"},"content":{"rendered":"<p><strong>Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer<\/strong><\/p>\n<p>BeiGene has announced that the U.S. Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab), a PD-1 protein inhibitor, in combination with chemotherapy as a first-line treatment for advanced gastric or gastroesophageal junction (G\/GEJ) adenocarcinoma.<\/p>\n<p>This approval expands Tevimbra&#8217;s indication in the U.S., where it was previously approved for the treatment of adult patients with unresectable or metastatic esophageal squamous cell carcinoma.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer BeiGene has announced that the U.S. Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab), a PD-1 protein inhibitor, in combination with chemotherapy as a first-line treatment for advanced gastric or gastroesophageal junction (G\/GEJ) adenocarcinoma. This approval expands Tevimbra&#8217;s indication [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":293,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[42],"class_list":{"0":"post-292","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-food-and-drug-organization","8":"tag-tevimbra-approved-combination-with-chemotherapy-as-first-line-treatment-for-a-type-gastric-cancer"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.1 (Yoast SEO v24.1) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer - whmnews<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer\" \/>\n<meta property=\"og:description\" content=\"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer BeiGene has announced that the U.S. Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab), a PD-1 protein inhibitor, in combination with chemotherapy as a first-line treatment for advanced gastric or gastroesophageal junction (G\/GEJ) adenocarcinoma. This approval expands Tevimbra&#8217;s indication [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"whmnews\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-04T10:55:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"474\" \/>\n\t<meta property=\"og:image:height\" content=\"265\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"whmnewsc_En\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"whmnewsc_En\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/\"},\"author\":{\"name\":\"whmnewsc_En\",\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/person\/fc7df78532f83795d668b0a84a5584f7\"},\"headline\":\"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer\",\"datePublished\":\"2025-01-04T10:55:24+00:00\",\"dateModified\":\"2025-01-04T10:55:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/\"},\"wordCount\":96,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/whmnews.ir\/En\/#organization\"},\"image\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp\",\"keywords\":[\"Tevimbra -Approved - Combination with Chemotherapy as First-Line Treatment - for a Type - Gastric Cancer\"],\"articleSection\":[\"Food and Drug Organization\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/\",\"url\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/\",\"name\":\"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer - whmnews\",\"isPartOf\":{\"@id\":\"https:\/\/whmnews.ir\/En\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp\",\"datePublished\":\"2025-01-04T10:55:24+00:00\",\"dateModified\":\"2025-01-04T10:55:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#primaryimage\",\"url\":\"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp\",\"contentUrl\":\"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp\",\"width\":474,\"height\":265},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/whmnews.ir\/En\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/whmnews.ir\/En\/#website\",\"url\":\"https:\/\/whmnews.ir\/En\/\",\"name\":\"whmnews\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/whmnews.ir\/En\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/whmnews.ir\/En\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/whmnews.ir\/En\/#organization\",\"name\":\"World Health and Medicine News\",\"url\":\"https:\/\/whmnews.ir\/En\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2024\/12\/logo-whmnews-1.png\",\"contentUrl\":\"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2024\/12\/logo-whmnews-1.png\",\"width\":387,\"height\":181,\"caption\":\"World Health and Medicine News\"},\"image\":{\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/person\/fc7df78532f83795d668b0a84a5584f7\",\"name\":\"whmnewsc_En\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/58e88c34f6c9235cf1acd6fe20f68fe705f3527187e36f73b2a1871e09e6490e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/58e88c34f6c9235cf1acd6fe20f68fe705f3527187e36f73b2a1871e09e6490e?s=96&d=mm&r=g\",\"caption\":\"whmnewsc_En\"},\"sameAs\":[\"http:\/\/whmnews.ir\/En\"],\"url\":\"http:\/\/whmnews.ir\/En\/index.php\/author\/whmnewsc_en\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer - whmnews","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer","og_description":"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer BeiGene has announced that the U.S. Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab), a PD-1 protein inhibitor, in combination with chemotherapy as a first-line treatment for advanced gastric or gastroesophageal junction (G\/GEJ) adenocarcinoma. This approval expands Tevimbra&#8217;s indication [&hellip;]","og_url":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/","og_site_name":"whmnews","article_published_time":"2025-01-04T10:55:24+00:00","og_image":[{"width":474,"height":265,"url":"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp","type":"image\/webp"}],"author":"whmnewsc_En","twitter_card":"summary_large_image","twitter_misc":{"Written by":"whmnewsc_En"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#article","isPartOf":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/"},"author":{"name":"whmnewsc_En","@id":"https:\/\/whmnews.ir\/En\/#\/schema\/person\/fc7df78532f83795d668b0a84a5584f7"},"headline":"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer","datePublished":"2025-01-04T10:55:24+00:00","dateModified":"2025-01-04T10:55:24+00:00","mainEntityOfPage":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/"},"wordCount":96,"commentCount":0,"publisher":{"@id":"https:\/\/whmnews.ir\/En\/#organization"},"image":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#primaryimage"},"thumbnailUrl":"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp","keywords":["Tevimbra -Approved - Combination with Chemotherapy as First-Line Treatment - for a Type - Gastric Cancer"],"articleSection":["Food and Drug Organization"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/","url":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/","name":"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer - whmnews","isPartOf":{"@id":"https:\/\/whmnews.ir\/En\/#website"},"primaryImageOfPage":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#primaryimage"},"image":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#primaryimage"},"thumbnailUrl":"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp","datePublished":"2025-01-04T10:55:24+00:00","dateModified":"2025-01-04T10:55:24+00:00","breadcrumb":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#primaryimage","url":"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp","contentUrl":"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2025\/01\/\u062f\u0627\u0631\u0648\u06cc-Tevimbra-\u062f\u0631-\u062a\u0631\u06a9\u06cc\u0628-\u0628\u0627-\u0634\u06cc\u0645\u06cc_\u062f\u0631\u0645\u0627\u0646\u06cc-\u0628\u0647_\u0639\u0646\u0648\u0627\u0646-\u062f\u0631\u0645\u0627\u0646-\u062e\u0637-\u0627\u0648\u0644-\u0628\u0631\u0627\u06cc-\u0646\u0648\u0639\u06cc-\u0633\u0631\u0637\u0627\u0646-\u0645\u0639\u062f\u0647-\u062a\u0627\u06cc\u06cc\u062f-\u0634\u062f.webp","width":474,"height":265},{"@type":"BreadcrumbList","@id":"https:\/\/whmnews.ir\/En\/index.php\/2025\/01\/04\/tevimbra-approved-in-combination-with-chemotherapy-as-first-line-treatment-for-a-type-of-gastric-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/whmnews.ir\/En\/"},{"@type":"ListItem","position":2,"name":"Tevimbra Approved in Combination with Chemotherapy as First-Line Treatment for a Type of Gastric Cancer"}]},{"@type":"WebSite","@id":"https:\/\/whmnews.ir\/En\/#website","url":"https:\/\/whmnews.ir\/En\/","name":"whmnews","description":"","publisher":{"@id":"https:\/\/whmnews.ir\/En\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/whmnews.ir\/En\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/whmnews.ir\/En\/#organization","name":"World Health and Medicine News","url":"https:\/\/whmnews.ir\/En\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/whmnews.ir\/En\/#\/schema\/logo\/image\/","url":"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2024\/12\/logo-whmnews-1.png","contentUrl":"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2024\/12\/logo-whmnews-1.png","width":387,"height":181,"caption":"World Health and Medicine News"},"image":{"@id":"https:\/\/whmnews.ir\/En\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/whmnews.ir\/En\/#\/schema\/person\/fc7df78532f83795d668b0a84a5584f7","name":"whmnewsc_En","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/whmnews.ir\/En\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/58e88c34f6c9235cf1acd6fe20f68fe705f3527187e36f73b2a1871e09e6490e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/58e88c34f6c9235cf1acd6fe20f68fe705f3527187e36f73b2a1871e09e6490e?s=96&d=mm&r=g","caption":"whmnewsc_En"},"sameAs":["http:\/\/whmnews.ir\/En"],"url":"http:\/\/whmnews.ir\/En\/index.php\/author\/whmnewsc_en\/"}]}},"_links":{"self":[{"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/posts\/292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/comments?post=292"}],"version-history":[{"count":2,"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/posts\/292\/revisions"}],"predecessor-version":[{"id":295,"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/posts\/292\/revisions\/295"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/media\/293"}],"wp:attachment":[{"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/media?parent=292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/categories?post=292"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/tags?post=292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}